Duration of study definition

Duration of study means period specified for students to complete the master’s degree study structure.
Sample 1Sample 2Sample 3
Duration of study means period specified for students to complete the master’s degree
Sample 1Sample 2
Duration of study means period of time specified for students to complete the master’s
Sample 1Sample 2

Examples of Duration of study in a sentence

  • Duration of study programmes without interrupting the study is 12 semesters, i.e. 6 years.

  • Duration of study with estimated start and finishes dates and proposed follow up period (with justification).

  • Duration of study: Full-timeLong SemesterShort SemesterNo. of Weeks No. of Semesters No. of Years Note: Number of weeks should include study and exam week.

  • Duration of study therapy longer than 21 days must be approved by the Sponsor.

  • Previous studies that have reported on radiological progression despite clinical improvement or inactivity are summarised below in table 1.3.Table 1.3 Studies on radiological deterioration despite clinical improvement or remission in RA Study & YearType of studyNo of patientsDuration of study Study & Year Type of study No of patients Duration of study Treatment Table 1.3 shows that few studies have already reported radiographic progression in spite of clinical improvement or disease inactivity in RA.

  • Duration of study per patient: Up to 28 days screening period, 13 weeks treatment period followed by 8 weeks follow up period.

  • Duration of study for the level: Duration of study at level (0) as a minimum is equivalent to at least two hours per day and for 100 days of educational activities per year.

  • Duration of study treatment exposure, cumulative dose and dose intensity will be summarized by treatment group.

  • Study design, number and characteristics of subjects, duration of study, wash-out period, settings and reduction in the glycaemic index*‌‌‌Study Design†Subjects ( n) Duration of study Wash-out period(weeks) Subject characteristics SettingGIreduction(units) Outcomes reported Bouche et al.

  • Duration of study participation and insert duration will also be tabulated.


More Definitions of Duration of study

Duration of study. Start: End: Crop: Let Farm Manager manage routine daily operations without consultation? □ Yes □ No Manpower requirements (estimated number of people, frequency) over course of season: Irrigation schedule (estimated frequency, requirements, who decides?): Chemical applications (which chemicals, application rates, schedule, pest scouting responsibilities): Harvest schedule (need farm crew or use students?): Special requirements: Other researchers associated with project: • Who will be primary contact? • Who will be billed? Potential interference with other projects (have these researchers been contacted?): Will there be any sales associated with this project? (NOTE: Sales agreements must have prior approval by the Director of the Agricultural Experiment Station.) What close-down costs will be incurred at the end of this project? How will they be paid? Additional information: Signature of Principal Investigator Date Signature of Farm Manager Date Signature of Superintendent Date
Sample 1
Duration of study means a period/duration for a student to fulfil all the requirements in his/her study for the conferment of the degree concerned;
Sample 1Sample 2
Duration of study. Start date: End date: Crop: Let farm manager manage routine daily operations without consultation: Yes No (By checking “No”, you agree to submitting a Work Order for each task or tasks requested) Hand Labor requirements (Estimated # of people, frequency) over course of season: Irrigation schedule, who decides? (If XX decides then Work Order is needed every irrigation): Principal Investigator Farm Manager Irrigation meter readings needed? Yes No Chemical applications (which chemicals, application rates, schedule, pest scouting responsibilities): Harvest needs (farm crew, students, mechanical): Special Requirements: Who will be primary contact? Email: Cell Phone: Potential interference with other projects (have these researchers been contacted): Will there be any sales associated with this project: If so, how are funds to be distributed?: What close-down costs will be incurred at the end of this project: Additional information: Signature of Principal Investigator: Date: Signature of Farm Manager: Date: Signature of Superintendent: Date: **Principal Investigator is responsible for ensuring that personnel working on their project have received Worker Protection Standard (WPS) training
Sample 1
Duration of study means a period determined for a student to fulfil all of the conditions of his study, to be conferred a degree;
Sample 1
Duration of study means the total number of semesters required to complete a course, as specified in the curriculum.
Sample 1

Related to Duration of study

  • Program of study means a curriculum that requires a candidate to demonstrate and document competency in the specific knowledge, skills, and dispositions for a particular endorsement to an educator’s license, a licensure content area, or level of licensure, and is:

  • Pivotal Trial means a controlled pivotal clinical trial of Licensed Technology that is prospectively designed to demonstrate statistically whether such Licensed Technology is effective and safe for use in a particular indication in a manner sufficient to obtain regulatory approval to market such product in the United States, European Union, or other foreign jurisdiction.

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Pivotal Study means (a) a Phase 3 Study that is intended by Celgene to be submitted (together with any other registration trials that are prospectively planned when such Phase 3 Study is initiated) for Regulatory Approval in the U.S. or the EU, or (b) any other clinical study that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which clinical study is a registration trial intended to be sufficient for filing an application for a Regulatory Approval for the Licensed Product in the U.S. or another country or some or all of an extra-national territory, solely as evidenced by the acceptance for filing for a Regulatory Approval for such product after completion of such study.

  • Board of Studies means the Board of Studies of the University;

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Dean of Students means the Dean of Students, his/her designee(s), or his/her representative(s).

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, or Pivotal Study, as applicable; but excluding any Post-Approval Studies.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Special Enrollment Period means a period of time allowed under this Plan, other than the eligible person’s Initial Enrollment Period or an Open Enrollment Period, during which an eligible person can request coverage under this Plan as a result of certain events that create special enrollment rights.

  • Initial Enrollment Period means one of the following periods during which you may first enroll for coverage under this plan:

  • Phase 1 Trial means, with respect to a Licensed Product, a clinical trial (or — in case of a multi-phase clinical trial — those parts of a clinical trial) in line with the provisions of 21CFR312, Section 21 (a).

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase III Clinical Trial means a human clinical trial, the principal purpose of which is to demonstrate clinically and statistically the efficacy and safety of a Licensed Product for one or more indications in order to obtain Marketing Approval of such Licensed Product for such indication(s), as further defined in 21 C.F.R. §312.21 or a similar clinical study in a country other than the United States.

  • Development Phase means the period before a vehicle type is type approved.